AICPI
ABG Innovation Capital Partners III Portfolio holdings
AUM
$49.9K
This Quarter Return
-5.97%
1 Year Return
+0.25%
3 Year Return
-18.22%
5 Year Return
–
10 Year Return
–
AUM
$204M
AUM Growth
+$204M
(+20%)
Cap. Flow
+$52.7M
Cap. Flow
% of AUM
25.9%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Atea Pharmaceuticals
AVIR
|
$110M |
Sector Composition
| 1 | Healthcare | 19.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pulmonx
LUNG
$69.7M
| $38.1M | 18.73% | 833,333 | – | – |
|
|
GNCA
2
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.02M | 0.5% | 375,000 | – | – |
|
3
Synlogic
SYBX
$17M
| $737K | 0.36% | 205,906 | – | – |
|
|
WHWK
4
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $516K | 0.25% | 400,000 | – | – |
|
|
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $76K | 0.04% | 45,849 | – | – |
|
|
ACGN
6
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $73K | 0.04% | 56,250 | – | – |
|
|
7
Atea Pharmaceuticals
AVIR
$267M
| – | – | -2,639,178 | Closed | -$110M |
|